RICHTER'S TRANSFORMATION
Clinical trials for RICHTER'S TRANSFORMATION explained in plain language.
Never miss a new study
Get alerted when new RICHTER'S TRANSFORMATION trials appear
Sign up with your email to follow new studies for RICHTER'S TRANSFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new drug called BGB-16673 for people with certain blood cancers (B-cell malignancies) that have come back or not responded to treatment. The goal is to find the best dose and see if it is safe and shrinks tumors. About 146 Chinese adults will take part in this …
Matched conditions: RICHTER'S TRANSFORMATION
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New hope for rare blood cancer: experimental drug targets Richter's transformation
Disease control Recruiting nowThis study tests a drug called ONO-4538 in 14 people with Richter's transformation, a rare and aggressive blood cancer that can develop from chronic lymphocytic leukemia. The goal is to see if the drug can shrink tumors and help people live longer. Participants must have a specif…
Matched conditions: RICHTER'S TRANSFORMATION
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
New hope for aggressive blood cancer: drug combo trial opens
Disease control Recruiting nowThis study tests a drug called glofitamab, alone or with other medicines, in people whose chronic lymphocytic leukemia has turned into a more aggressive lymphoma (Richter's transformation). About 70 adults will receive treatment to see if the cancer shrinks or disappears. The goa…
Matched conditions: RICHTER'S TRANSFORMATION
Phase: PHASE2 • Sponsor: Christine Ryan • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Massive new registry tracks 8,000 blood cancer patients for decades
Knowledge-focused Recruiting nowThis study is a long-term registry that follows up to 8,000 people with chronic lymphocytic leukemia (CLL) and similar blood cancers. It does not test any new treatment but instead collects information on survival and disease course over many years. Participants must be 18 or old…
Matched conditions: RICHTER'S TRANSFORMATION
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC